Thus, treatment of cells with CDK4/6i creates a highly favorable cellular environment for viral genome replication and has even the ability to convert XVir-N-31 at very low MOI from a non-replicative into a replication-competent status in cancer cells. This evidence concerns the gene CDK4 and cancer.